Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 20/20 | 1.00 |
| ▸ | ITGA2B | P08514 | 20/20 | 1.00 |
| ▸ | ITGAV | P06756 | 2/20 | 0.77 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.77 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.77 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7273893 | 0.99 | ITGB3 (0.98) | ITGB3ITGA2BITGAVCHRM2SLC6A4 | |
| SCHEMBL7357656 | 0.92 | ITGB3 (1.00) | ITGB3ITGA2BITGAVCHRM2SLC6A4 | |
| SCHEMBL7441599 | 0.91 | ITGB3 (0.83) | ITGB3ITGA2BITGAVCHRM2SLC6A4 | |
| Hydrochloric Acid SCHEMBL7441855 | 0.91 | ITGB3 (0.98) | ITGB3ITGA2BITGAVCHRM2SLC6A4 | |
| Hydrochloric Acid SCHEMBL7271682 | 0.88 | ITGB3 (0.98) | ITGB3ITGA2BITGAVCHRM2SLC6A4 | |
| Hydrochloric Acid SCHEMBL7383505 | 0.87 | ITGB3 (0.77) | ITGB3ITGA2BITGAVCHRM2SLC6A4 | |
| Tirofiban SCHEMBL3685 | 0.87 | ITGB3 (1.00) | ITGB3ITGA2BITGAVCHRM2SLC6A4 | |
| Tirofiban SCHEMBL17721319 | 0.87 | ITGB3 (1.00) | ITGB3ITGA2BITGAVCHRM2SLC6A4 | |
| Tirofiban SCHEMBL618214 | 0.87 | ITGB3 (1.00) | ITGB3ITGA2BITGAVCHRM2SLC6A4 | |
| Hydrochloric Acid SCHEMBL7438644 | 0.86 | ITGB3 (0.98) | ITGB3ITGA2BITGAVCHRM2SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0859634-B1 | PHARMACEUTICAL COMPOSITIONS CONTAINING PLATELET AGGREGATION INHIBITORS | MERCK & CO INC (US) | 2002-02-27 | — | — | EP | disclosed |
| US-5972967-A | INTRAVENOUS ADMINISTERING 2-(BUTYLSULFONYLAMINO)-3-(4-(4-(PIPERIDIN-4-YL)BUTOXYPHENYL)PR OPIONIC ACID | MERCK & CO., INC. (US) | 1999-10-26 | — | — | US | disclosed |
| US-5965581-A | COMPOSITION OF 2-S-(N-BUTYLSULFONYLAMINO)-3-(4-(4-(PIPERIDIN-4-YL)BUTYLOXY)PHENYL)PROPIONIC ACID, SODIUM CHLORIDE, SODIUM CITRATE DIHYDRATE, AND CITRIC ACID ANHYDROUS, OF SPECIFIC OSMOLALITY; PREVENTS THROMBOSIS | MERCK & CO., INC. (US) | 1999-10-12 | — | — | US | disclosed |
| EP-0859634-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING PLATELET AGGREGATION INHIBITORS | Merck & Co., Inc. (US) | 1998-08-26 | — | — | EP | disclosed |
| WO-1997015328-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING PLATELET AGGREGATION INHIBITORS | MERCK & CO., INC. (US) | 1997-05-01 | — | — | WO | disclosed |